Individualizing dual antiplatelet therapy (DAPT) duration based on bleeding risk, ischemic risk, or both: an analysis from the DAPT study - Mihatov, N; Secemsky, E A; Kereiakes, D J (Cardiovasc Revasc Med, 2022)